Venous thromboembolism (VTE)
Showing 1 - 25 of 4,971
Venous Thromboembolism (VTE) Trial (Additional blood sampling)
Not yet recruiting
- Venous Thromboembolism (VTE)
- Additional blood sampling
- (no location specified)
Sep 26, 2023
Extended Versus Conventional Duration of Enoxaparin Prophylaxis
Not yet recruiting
- Venous Thromboembolism
- (no location specified)
Apr 6, 2023
Xarelto for Venous Thromboembolism (VTE)
Completed
- Venous Thromboembolism
- Rivaroxaban (Xarelto, BAY59-7939)
-
Multiple Locations, JapanMany locations
Oct 30, 2022
Learn About Venous Thromboembolism Treatment With Rivaroxaban in
Completed
- Treatment of Venous Thromboembolism
- Rivaroxaban (Xarelto, BAY59-7939)
-
Japan Databases, Japan
- +1 more
Jan 10, 2023
Safety of Rivaroxaban in Children Under 2 Years Old With Venous
Not yet recruiting
- Venous Thromboembolism
- Children Under 2 Years
- Rivaroxaban (Xarelto, BAY59-7939)
- Standard of care (SOC)
-
Multiple Locations, Denmark
- +3 more
Jun 9, 2023
Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma Trial in Boston (Aspirin 325mg, Enoxaparin 40Mg/0.4mL Prefilled Syringe)
Enrolling by invitation
- Sarcoma
- +6 more
- Aspirin 325mg
- Enoxaparin 40Mg/0.4mL Prefilled Syringe
-
Boston, MassachusettsSantiago Lozano-Calderon
Jan 20, 2023
Acute Coronary Syndrome Trial in Shatin (CSL112, Placebo)
Not yet recruiting
- Thromboembolism
- No intervention as this is an observational study
-
Shatin, Hong KongThe Chinese University of Hong Kong
Nov 1, 2022
Compare Health Care Costs Between Apixaban and Low Molecular
Active, not recruiting
- Thromboembolism
-
New York, New YorkPfizer Investigational
Dec 1, 2022
ELIQUIS Regulatory Post-Marketing Surveillance In Clinical
Completed
- Venous Thromboembolism
-
Shinjuku-ku, Tokyo, JapanLocal Institution
Feb 3, 2022
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Detroit (Abelacimab, Dalteparin)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Dalteparin
-
Detroit, MichiganHenry Ford Health System
Jul 18, 2022
Europe Based on Medical Records That Looks at Safety of
Not yet recruiting
- Venous Thromboembolism
- Dabigatran Etexilate (DE)
- (no location specified)
Sep 9, 2022
NOACs Use in AF or VTE (SUNSHINE Registry)
Recruiting
- Atrial Fibrillation
- +2 more
- Patients with Atrial Fibrillation (AF) or venous thromboembolism (VTE)
-
Zhengzhou, Henan, ChinaHenan Provincial People's Hospital
Jun 6, 2022
Venous Thromboembolism, Deep Venous Thrombosis, Pulmonary Embolism Trial in Canada, United States (Abelacimab, Apixaban)
Recruiting
- Venous Thromboembolism
- +2 more
- Abelacimab
- Apixaban
-
Lexington, Kentucky
- +2 more
Jun 6, 2022
Chemical Venous Thromboembolism Prophylaxis in Trauma
Enrolling by invitation
- Thromboembolism, Venous
-
Dallas, TexasMethodist Dallas Medical Center Pharmacy
Sep 1, 2023
Intimate Partner Violence asRisk Factor for Venous
Recruiting
- Venous Thrombosis
- WAST questionnaire
-
Nîmes Cedex 09, FranceCHU de Nîmes - Hôpital Universitaire Carémea
Jun 9, 2023
Gather Information How Often Venous Thromboembolism Occurs in
Completed
- Venous Thromboembolism (VTE)
- Rivaroxaban (Xarelto, BAY59-7939)
- +2 more
-
Multiple Locations, SwedenMany Locations
Nov 24, 2021
Venous Thromboembolic Disease, Pulmonary Embolism, Venous Thromboembolism Trial (The multifaceted interventions, Routine VTE
Recruiting
- Venous Thromboembolic Disease
- +4 more
- The multifaceted interventions
- Routine VTE prophylaxis
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Jan 19, 2023
Efficacy of ICU-VTE Scale in ICU Patients
Recruiting
- Venous Thromboembolism
-
Wuhan, Hubei, ChinaThe Central Hospital of Wuhan
Aug 2, 2022
System Based on Big Data Analysis and Multimodule System
Recruiting
- Recruiting
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Jul 23, 2023
Venous Thromboembolism, Urologic Cancer Trial (Rivaroxaban 10 MG, Placebo control)
Not yet recruiting
- Venous Thromboembolism
- Urologic Cancer
- Rivaroxaban 10 MG
- Placebo control
- (no location specified)
Jun 16, 2023
Anticoagulation in Venous Thromboembolism and Cancer
Active, not recruiting
- Neoplasms
- Embolism
- Apixaban
- +5 more
-
London, United KingdomPfizer Investigational Site
Nov 17, 2022
Venous Thromboembolism, Venous Thromboses, Pulmonary Embolism Trial in Netherlands (Randomised treatment advice (discontinue vs
Recruiting
- Venous Thromboembolism
- +3 more
- Randomised treatment advice (discontinue vs continue after 3 months)
- +4 more
-
Leiden, South-Holland, Netherlands
- +16 more
Oct 17, 2023
Intracranial Hemorrhage in Glioma Venous Thromboembolism
Terminated
- Glioma, Malignant
- Observation of ICH and VTE
-
Sacramento, California
- +1 more
Aug 5, 2022
Major Bleeding in Participants Who Received Blood Thinning
Completed
- Venous Thromboembolism (VTE)
-
Princeton, New JerseyLocal Institution
Feb 10, 2022